Tamer Khayal, M.D., currently serves as the Chief Commercial Officer at TransMedics Group Inc., a pioneering medical technology company focused on organ transplant solutions. Dr. Khayal brings a wealth of experience to his role, having spent over two decades in the medical and healthcare industry. Prior to joining TransMedics, he held significant positions at leading healthcare organizations, including serving as the Vice President and General Manager of the Cardiac Rhythm and Heart Failure business at Abbott Laboratories. His tenure at Abbott was marked by strategic growth initiatives and the successful launch of innovative medical devices that improved patient outcomes. Dr. Khayal's academic background is equally impressive, with a medical degree from Cairo University and an MBA from Kellogg School of Management at Northwestern University. His dual expertise in medicine and business has uniquely positioned him to drive TransMedics' commercial strategy. At TransMedics, Dr. Khayal is responsible for overseeing the company's global commercial operations, including sales, marketing, and customer support. His leadership has been instrumental in expanding the reach of TransMedics' Organ Care System (OCS), a revolutionary technology that preserves organs in a near-physiological state, thereby increasing the viability of organs for transplantation. Under Dr. Khayal's guidance, TransMedics has achieved significant milestones, including the expansion of its product portfolio and the successful navigation of regulatory landscapes in multiple countries. His strategic vision and commitment to improving patient care have not only enhanced TransMedics' market position but also contributed to the broader field of organ transplantation. Dr. Khayal's role as Chief Commercial Officer is pivotal in ensuring that TransMedics continues to innovate and deliver life-saving solutions to patients worldwide.